PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.67%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.50%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
1.09%
Positive EBIT growth while BIDU is negative. John Neff might see a substantial edge in operational management.
1.09%
Positive operating income growth while BIDU is negative. John Neff might view this as a competitive edge in operations.
-26.11%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-25.71%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-25.71%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.29%
Share count expansion well above BIDU's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.15%
Slight or no buyback while BIDU is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
3.98%
OCF growth of 3.98% while BIDU is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
31.18%
FCF growth of 31.18% while BIDU is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
973.53%
10Y revenue/share CAGR under 50% of BIDU's 9029.81%. Michael Burry would suspect a lasting competitive disadvantage.
137.85%
5Y revenue/share CAGR under 50% of BIDU's 873.73%. Michael Burry would suspect a significant competitive gap or product weakness.
54.90%
3Y revenue/share CAGR under 50% of BIDU's 196.78%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
876.53%
OCF/share CAGR of 876.53% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
139.11%
OCF/share CAGR of 139.11% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
71.15%
3Y OCF/share CAGR of 71.15% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
644.16%
Below 50% of BIDU's 32009.26%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
67.88%
Below 50% of BIDU's 404.67%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
16.21%
3Y net income/share CAGR 50-75% of BIDU's 29.35%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
2373.53%
Below 50% of BIDU's 334803.57%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
164.51%
Below 50% of BIDU's 927.29%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
67.91%
Below 50% of BIDU's 215.05%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.97%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-35.93%
Inventory is declining while BIDU stands at 23.64%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.73%
Asset growth at 50-75% of BIDU's 3.09%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.48%
50-75% of BIDU's 5.03%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-0.04%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-2.13%
Our R&D shrinks while BIDU invests at 7.06%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-6.75%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.